Welcome to our dedicated page for The Advisory Board news (Ticker: ABCO), a resource for investors and traders seeking the latest updates and insights on The Advisory Board stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect The Advisory Board's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of The Advisory Board's position in the market.
Amulet Capital (private firm) appointed Adam Grossman as Partner effective May 4, 2026. Grossman brings 30+ years in healthcare operations, corporate strategy, investing, and transaction execution, and will focus on sourcing, structuring, and scaling healthcare services platforms.
His background includes roles at Deerfield Management, The Advisory Board Company (NASDAQ: ABCO), Health Evolution Partners, Aetna, and McKinsey, plus an A.B. from Dartmouth and an M.B.A. from Harvard.